Physician

Surjeet Singh Dheer, DO

According to 2025 Medicare claims, Surjeet Dheer, DO (NPI: 1689024143) practices internal medicine in the Wilmington, DE-MD-NJ market, with the plurality of this provider's patient population coming from New Castle, DE. This provider's primary affiliated billing organization is INFUSION SOLUTIONS OF DELAWARE (NPI: 1073614103; TIN: 010863383) and primary practice location at 19713-2145.

Dheer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 466 traditional Medicare patients, billed 180,843 HCPCS/CPT codes, and received $1,813,572 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,375 prescription claims across 291 beneficiaries totaling $1,249,637 in drug costs, led by Tremfya (Guselkumab). Open Payments data shows 86 records totaling $1,819. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $21,166 to $1,813,572. Similarly, Part D prescription costs have moved sharply higher in recent years, from $10,168 to $1,249,637. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$907K$1.8M2019 Medicare payment: $21,166 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $14,890 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $165,490 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,154,106 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,813,572 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019133172$21,166
2020120190$14,890
2021N/RN/RN/R
20223023,606$165,490
202344176,297$1,154,106
2024466180,843$1,813,572

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$625K$1.2M2016 Drug cost: $10,168 (USD; Tot_Drug_Cst)2017 Drug cost: $10,722 (USD; Tot_Drug_Cst)2018 Drug cost: $12,387 (USD; Tot_Drug_Cst)2019 Drug cost: $20,331 (USD; Tot_Drug_Cst)2020 Drug cost: $2,288 (USD; Tot_Drug_Cst)2021 Drug cost: $4,275 (USD; Tot_Drug_Cst)2022 Drug cost: $282,540 (USD; Tot_Drug_Cst)2023 Drug cost: $1,103,155 (USD; Tot_Drug_Cst)2024 Drug cost: $1,249,637 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161543$10,168
201754153$10,722
201841155$12,387
201958188$20,331
20201631$2,288
20211883$4,275
2022162390$282,540
20232501,228$1,103,155
20242911,375$1,249,637

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more7373$114
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more363646$91
99442Telephone medical discussion with physician, 11-20 minutes6270$63
J0897Injection, denosumab, 1 mg15714,460$20
96372Injection of drug or substance under skin or into muscle173275$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TremfyaGuselkumab14784$195,214
EnbrelEtanercept11560$144,759
TymlosAbaloparatide361,620$140,364
SimponiGolimumab11308$72,314
ForteoTeriparatide13492$69,719

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.86$1,819UCB, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Surjeet Singh Dheer, DO?

Tedicare shows public-source Medicare data for Surjeet Singh Dheer, DO (NPI 1689024143), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Surjeet Singh Dheer, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Surjeet Singh Dheer, DO?

Surjeet Singh Dheer, DO is linked to INFUSION SOLUTIONS OF DELAWARE (billing NPI 1073614103) in the available physician profile data.

Does Surjeet Singh Dheer, DO have Open Payments data?

Surjeet Singh Dheer, DO has 86 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.